Skip to main content
Premium Trial:

Request an Annual Quote

DeCode s Nuptials With MediChem May Come Sooner Than Planned

NEW YORK, Feb. 21 - DeCODE Genetics will likely acquire MediChem Life Sciences faster that it expected.

 

On Thursday the companies said that the US Federal Trade Commission has ended the Hart-Scott-Rodino waiting period ahead of time, meaning that the proposed merger is now expected to close in mid-March, several weeks before the firms originally expected the deal to close.

The transaction is still subject to a vote by MediChem stockholders, who are set to gather at a meeting on March 14.

As GenomeWeb reported, deCode in early January announced plans to acquire MediChem in a stock-swap deal valued at roughly $84 million. The deal is hoped to bolster the Icelandic population genomics company's chemistry and structural proteomics technology and to accelerate its progress toward in-house drug discovery and development.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.